Skip to main content

Transmissible Spongiform Encephalopathies (TSE): TGA approach to minimising the risk of exposure

How the TGA assesses the safety of materials derived from human and other animal species, naturally susceptible to TSE, that are used in the manufacture of therapeutic goods.

Last updated

Help us improve the Therapeutic Goods Administration site